SIBN250117P30000
- 0.00
- 0.000.00%
Si-Bone Newsroom
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Osteotec Appointed as Exclusive Distributor for Cerapedics in the UK and Ireland
Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $15
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
Don't Ignore The Insider Selling In SI-BONE
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
SI-Bone: Capitalizing on Market Weakness Amid Favorable Medicare Payment Analysis
SI-BONE Down Over 15%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk
SI-BONE Shares Are Trading Lower After the Company Reported Mixed Q3 Financial Results and Narrowed Its FY24 Revenue Guidance.
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $18
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $18 to $32
SI-BONE Price Target Maintained With a $19.00/Share by Needham
SI-BONE Analyst Ratings
SI-Bone's Strong Sales Growth and Innovative Product Pipeline Support Continued Buy Rating
Express News | SI-BONE Inc : Jefferies Cuts Target Price to $25 From $28
SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript Summary
Si-Bone | 10-Q: Q3 2024 Earnings Report
SI-BONE GAAP EPS of -$0.16 Beats by $0.08, Revenue of $40.3M Misses by $0.19M